Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2023 | Prevention of VTE in patients with hemorrhagic stroke

Patients with hemorrhagic stroke have a significantly higher risk of in-hospital venous thromboembolism (VTE) than patients with ischemic stroke. Senta Frol, MD, PhD, University Medical Centre Ljubljana, Ljubljana, Slovenia, discusses the use of preventive anticoagulation therapy in patients with hemorrhagic stroke. Decision-making on anticoagulation spurs debates among clinicians because of the concern that anticoagulants may increase the risk of recurrent intracerebral hemorrhage and hematoma expansion. Since preventive anticoagulation is important in these patients due to the risk of VTE, the availability of tests to monitor hypo-or hypercoagulability status in ICH patients could be helpful in clinical practice. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.